December 20, 2023 07:34 AM ESTUpdated 08:07 AM
Deals
China

GSK se­cures an­oth­er ex-Chi­na ADC deal with Han­soh Phar­ma with $185M up­front

Reynald Castañeda

Deputy Editor

The year of an­ti­body-drug con­ju­gates isn’t done yet, as GSK is adding an­oth­er li­cens­ing part­ner­ship with Han­soh Phar­ma for an­oth­er ADC with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ab­b­Vie makes an­oth­er small I&I ac­qui­si­tion, buy­ing Nim­ble for $200M

Gilead names Di­et­mar Berg­er CMO as it eyes R&D re­set

Xaira hires for­mer Roche ex­ec as CMO; 'Tis the sea­son for re­tire­ments at Al­ny­lam, Re­gen­eron

Ed­i­tas to cut 65% of work­force, of­fi­cial­ly stops work on ex vi­vo sick­le cell ther­a­py

Bound­less shares dip as it nix­es can­cer as­set, reshuf­fles ex­ecs

sponsored

The key to faster, more im­pact­ful re­search? Put pa­tients in the dri­ver’s seat

A service from the Financial Times